Real-world treatment patterns of palbociclib and blood count monitoring in patients with advanced breast cancer in Japan (vol 18, pg 2101, 2022)

被引：0
|
作者：
Sawaki, Masataka
Muramatsu, Yasuaki
Togo, Kanae
Laurent, Thomas
Iwata, Hiroji
机构：
来源：
FUTURE ONCOLOGY | 2023年
关键词：
D O I：
10.2217/fon-2021-1448c1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-world treatment patterns of palbociclib and blood count monitoring in patients with advanced breast cancer in Japan
    Sawaki, Masataka
    Muramatsu, Yasuaki
    Togo, Kanae
    Laurent, Thomas
    Iwata, Hiroji
    FUTURE ONCOLOGY, 2022, 18 (17) : 2101 - 2111
  • [2] Real-world treatment patterns of subsequent therapy after palbociclib in patients with advanced breast cancer in Japan
    Sawaki, Masataka
    Muramatsu, Yasuaki
    Togo, Kanae
    Iwata, Hiroji
    BREAST, 2023, 70 : 1 - 7
  • [3] REAL-WORLD OUTCOMES OF PATIENTS WITH ADVANCED BREAST CANCER TREATED WITH PALBOCICLIB: A MULTICENTER RETROSPECTIVE COHORT STUDY IN JAPAN
    Odan, Nina
    Kikawa, Yuichiro
    Matsumoto, Hajime
    Minohata, Junya
    Suwa, Hirohumi
    Hashimoto, Takashi
    Okuno, Toshitaka
    Miyashita, Masaru
    Saito, Masaru
    Yamagami, Kazuhiko
    Takao, Shintaro
    BREAST, 2019, 48 : S49 - S49
  • [4] The safety and efficacy of palbociclib in older patients with advanced breast cancer in a real-world setting
    Gouton, Etienne
    Tassy, Louis
    Micallef, Joelle
    Meskine, Amir
    Sabatier, Renaud
    Cecile-Herry, Maud
    Braticevic, Cecile
    Goncalves, Anthony
    Viret, Frederic
    de Nonneville, Alexandre
    Montegut, Coline
    Rouby, Franck
    Rousseau, Frederique
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2022, 8
  • [5] Real-world safety of palbociclib in breast cancer patients in the United States
    Beachler, Daniel C.
    de Luise, Cynthia
    Jamal-Allial, Aziza
    Yin, Ruihua
    Taylor, Devon H.
    Lanes, Stephan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 603 - 603
  • [6] Real-world treatment patterns for palbociclib plus an aromatase inhibitor, or an aromatase inhibitor alone, for patients with metastatic breast cancer in the Flatiron Database (vol 154, pg 701, 2024)
    Rugo, H. S.
    Liu, X.
    Li, B.
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (01) : E2 - E2
  • [7] Treatment patterns, effectiveness, and patient-reported outcomes of palbociclib therapy in Chinese patients with advanced breast cancer: A multicenter ambispective real-world study
    Shen, Lesang
    Zhou, Jun
    Chen, Yiding
    Ding, Jinhua
    Wei, Haiyan
    Liu, Jian
    Xia, Wenjie
    Xie, Bojian
    Xie, Xiaohong
    Li, Xujun
    Dai, Yuechu
    Zhang, Guobing
    Qiu, Xia
    Li, Chao
    Sun, Shanshan
    Chen, Wuzhen
    Gong, Dihe
    Li, Hengyu
    Huang, Jian
    Jiang, Xia
    Ni, Chao
    CANCER MEDICINE, 2022, 11 (22): : 4157 - 4168
  • [8] Real-world treatment patterns among metastatic cervical cancer patients in Japan
    Ando, Hiroshi
    Bains, Savreet
    Tang, Wenxi
    Swallow, Elyse
    ANNALS OF ONCOLOGY, 2022, 33 : S476 - S477
  • [9] Patterns of treatment and outcomes in real world patients with advanced estrogen receptor positive breast cancer receiving palbociclib and endocrine therapy
    Prior, Lisa
    Skrobo, Darko
    Murray, Hazel
    Farooq, Abdul Rehman
    Horgan, Anne
    Calvert, Paula
    Jordan, Emmet
    McCaffrey, John
    Smyth, Lillian
    O'Connor, Miriam
    Higgins, Michaela
    Carney, Desmond
    Walshe, Janice
    Gullo, Giuseppe
    Crown, John
    Kelly, Catherine M.
    CANCER RESEARCH, 2021, 81 (04)
  • [10] Real-world treatment patterns and clinical outcomes in patients receiving palbociclib combinations for HR+/HER2- advanced/metastatic breast cancer in Japan: Results from the IRIS study
    Mycock, Katie
    Zhan, Lin
    Hart, Kieran
    Taylor-Stokes, Gavin
    Milligan, Gary
    Atkinson, Christian
    Mitra, Debanjali
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 32
12345